A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2018
Price : $35 *
At a glance
- Drugs Squaric acid dibutylester (Primary)
- Indications Herpes labialis
- Focus Adverse reactions
- Sponsors Squarex
- 01 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Oct 2018.
- 01 Aug 2018 Status changed from recruiting to suspended.
- 14 May 2018 New trial record